Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-endotoxin monoclonal antibodies.

× No keyword cloud information.

41 in total

1. Pediatric infectious diseases: future campaigns.

Authors: A Kumar; S Chaudhary
Journal: Indian J Pediatr Date: 1995 Jan-Feb Impact factor: 1.967

Review 2. Cytokines in infectious diseases.

Authors: S B Boppana
Journal: Indian J Pediatr Date: 1996 Jul-Aug Impact factor: 1.967

3. Septic Shock and Toxic Shock: Do Adjunctive Therapies Improve Outcome?

Authors:
Journal: Curr Infect Dis Rep Date: 1999-08 Impact factor: 3.725

Review 4. Drug utilisation review and pharmacoeconomics: interaction after parallel development?

Authors: S Garattini; G Tognoni
Journal: Pharmacoeconomics Date: 1993-09 Impact factor: 4.981

Review 5. Pharmacoeconomics of antibacterial treatment.

Authors: P G Davey; M M Malek; S E Parker
Journal: Pharmacoeconomics Date: 1992-06 Impact factor: 4.981

6. Novel monoclonal antiendotoxin antibody therapy: efficacy at any price?

Authors: W K Fant
Journal: Pharmacoeconomics Date: 1993-06 Impact factor: 4.981

7. Once is not enough: clinical trials in sepsis.

Authors: Daniel A Sweeney; Robert L Danner; Peter Q Eichacker; Charles Natanson
Journal: Intensive Care Med Date: 2008-10-07 Impact factor: 17.440

Review 8. Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.

Authors: J C Hurley
Journal: Drugs Date: 1994-06 Impact factor: 9.546

9. In vitro reduction of endotoxin concentrations with the 5S fragment of immunoglobulin G.

Authors: D Xuan; D P Nicolau; P R Tessier; L Bow; R Quintiliani; C H Nightingale
Journal: Antimicrob Agents Chemother Date: 1997-07 Impact factor: 5.191

10. The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35).

Authors: M Tonoli; K A Davies; P J Norsworthy; J Cohen; M J Walport
Journal: Clin Exp Immunol Date: 1993-05 Impact factor: 4.330